X-Vax Technology (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- July 23, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $56,000,000
Company Info
- Company Description
- X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.
- Market
- Vaccine Development
- Location
- Jupiter, Florida, USA
- Coinvestors
- Adjuvant Capital, Alexandria Venture Investments, Founders Fund, Johnson & Johnson Innovation, Serum Institute of India